Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

CEFADROXIL 1 GM TABLET

Cefadroxil
$3.9135per EA
High Outlier

Strength

1000 mg/1

Manufacturer

Teva Pharmaceuticals USA Inc.

NDC

00093405953

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

CEFADROXIL

Approval Type

Generic (ANDA)

FDA Application

ANDA062774

On Market Since

1/31/2007

Pharmacological Classes

Cephalosporin Antibacterial
Cephalosporins

Price History

1W

0.0%

1M

-3.8%

3M

-6.3%

6M

-4.0%

1Y

+6.0%

3Y

+43.3%

5Y

N/A

All

+43.3%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Related Drugs

Same classification

CEPHALEXIN 250 MG/5 ML SUSP
Generic
00093417774•Teva Pharmaceuticals USA Inc.
$0.0513
per ML
CEPHALEXIN 250 MG/5 ML SUSP
Generic
62135048149•Chartwell RX LLC
$0.0513
per ML
CEPHALEXIN 250 MG/5 ML SUSP
Generic
67877054568•Ascend Laboratories, LLC
$0.0513
per ML
CEPHALEXIN 250 MG/5 ML SUSP
Generic
68180044102•Lupin Pharmaceuticals Inc.
$0.0513
per ML
CEPHALEXIN 125 MG/5 ML SUSP
Generic
00093417574•Teva Pharmaceuticals USA Inc.
$0.0535
per ML
CEPHALEXIN 125 MG/5 ML SUSP
Generic
62135048049•Chartwell RX LLC
$0.0535
per ML
CEPHALEXIN 125 MG/5 ML SUSP
Generic
67877054468•Ascend Laboratories, LLC
$0.0535
per ML
CEPHALEXIN 125 MG/5 ML SUSP
Generic
68180044002•Lupin Pharmaceuticals Inc.
$0.0535
per ML
CEPHALEXIN 125 MG/5 ML SUSP
Generic
00093417573•Teva Pharmaceuticals USA Inc.
$0.0678
per ML
CEPHALEXIN 125 MG/5 ML SUSP
Generic
62135048042•Chartwell RX LLC
$0.0678
per ML

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy